|

Consolidation treatment (With ICIs) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • Shandong Cancer Hospital and Institute1

Indications

  • Local Advanced Rectal Cancer1
  • Radiotherapy1
  • Immunotherapy1
  • Cancer1

Other1 trial

Short-Course Radiotherapy Followed by CAPOX With or Without Iparomlimab and Tuvonralimab in pMMR/MSS Locally Advanced Rectal Cancer
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.